The Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.


The Cure Starts Now has funded $23,608,247 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 150 grants at over 100 hospitals in 17 countries.




CONNECT Consortium - $893,678.37

Amount
$893,678.00
Date
September 2017

CONNECT (COllaborative Network for NEurooncology Clinical Trials) Consortium

University of Massachusetts Medical School - $50,000

Amount
$50,000.00
Date
May 2017

Advanced RNAi therapeutics for DIPG

Lucile Packard Children's Hospital Stanford - $50,000

Amount
$50,000.00
Date
May 2017

Cellular Cybercriminals: DIPG Hacks into the Neural Communication Infrastructure

Hospital for Sick Children - $50,000

Amount
$50,000.00
Date
September 2016

MRI Guided Focused Ultrasound: Targeted Drug Delivery in Diffuse Intrinsic Pontine Glioma

Gustave Roussy Cancer Center - $93,071

Amount
$93,071.00
Date
September 2016

Ultrasound-induced delivery of Panobinostat in preclinical models

The Hospital for Sick Children - $194,260

Amount
$194,260.00
Date
September 2016

Exploring the interactome of H3K27M to find therapeutic targets for DIPG

Cold Spring Harbor Laboratory - $100,000

Amount
$100,000.00
Date
September 2016

Allele-specific antisense therapy for DIPG

Children's Cancer Institute - $143,884

Amount
$143,884.00
Date
September 2016

Radiosensitisation of Diffuse Intrinsic Pontine Gliomas by modulating the glucose metabolism

Dana-Farber Cancer Institute - $100,000

Amount
$100,000.00
Date
December 2015

Characterizing resistance mechanisms to radiation therapy and adjuvant chemotherapy in Diffuse Intrinsic Pontine Glioma

Cincinnati Children's Hospital Medical Center - $100,000

Amount
$100,000.00
Date
December 2015

An early Phase 2 Study of LEE011, a CDK4/6 Inhibitor, following radiation therapy in Children with Newly Diagnosed non-biopsied Diffuse Pontine Gliomas (DIPG) and Rb+ biopsied DIPG and High Grade Gliomas (HGG)

Baylor College of Medicine/Texas Children's Hospital - $200,000

Amount
$200,000.00
Date
December 2015

Targeting DIPGs through Super-activation of Steroid Receptor Co-activators: An in vivo Study in Patient-derived Intra-brain Stem Xenograft Mouse Models

Children's National Health System and Children's Research Institute - $125,000

Amount
$125,000.00
Date
December 2015

Comprehensive Molecular-Based Cross-Species Comparison of DIPG Biology

Boston Children's Hospital - $110,000

Amount
$110,000.00
Date
December 2015

Enabling epigenetic therapies by exploring DIPG chromatin sensitivities

UCL Institute of Child Health - $200,000

Amount
$200,000.00
Date
December 2015

T-cell based immunotherapy for DIPG.

Dana Farber Cancer Institute - $100,000

Amount
$100,000.00
Date
December 2015

Discovering novel epigenetic dependencies in Diffuse Intrinsic Pontine Glioma